Literature DB >> 6832089

Cell specificity in DNA binding and repair of chemical carcinogens.

J A Swenberg, D E Rickert, B L Baranyi, J I Goodman.   

Abstract

Many animal models for organ specific neoplasia have been developed and used to study the pathogenesis of cancer. Morphologic studies have usually concentrated on the response of target cells, whereas biochemical investigations have usually employed whole organ homogenates. Since hepatocytes comprise nearly 90% of the liver's mass and 70-80% of its DNA, alterations in DNA replication, covalent binding and DNA repair of nonparenchymal cells are usually obscured when whole organ homogenates are used. By utilizing cell separation methods, we have been able to demonstrate differences between hepatocyte and nonparenchymal cell replication. DNA damage and repair following exposure to a variety of hepatocarcinogen. Differences in removal of simple O6-alkylguanine and DNA replication correlate with cell specific carcinogenesis of simply alkylating agents. For several other procarcinogens, including 2-acetylaminofluorene and dinitroluene, cell specificity appears to reside primarily in the differential metabolic competence of hepatocytes and nonparenchymal cells. This results in greater covalent binding of the carcinogen to hepatocyte DNA, although the DNA adducts are removed at a similar rate in both cell types.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6832089      PMCID: PMC1569133          DOI: 10.1289/ehp.8349155

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  31 in total

1.  Separation of Kupffer and endothelial cells of the rat liver by centrifugal elutriation.

Authors:  D L Knook; E C Sleyster
Journal:  Exp Cell Res       Date:  1976-05       Impact factor: 3.905

2.  Modification of diethylnitrosamine liver carcinogenesis with phenobarbital but not with immunosuppression.

Authors:  J H Weisburger; R M Madison; J M Ward; C Viguera; E K Weisburger
Journal:  J Natl Cancer Inst       Date:  1975-05       Impact factor: 13.506

Review 3.  The chemical effects of nucleic acid alkylation and their relation to mutagenesis and carcinogenesis.

Authors:  B Singer
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1975

Review 4.  Sites in nucleic acids reacting with alkylating agents of differing carcinogenicity of mutagenicity.

Authors:  B Singer
Journal:  J Toxicol Environ Health       Date:  1977-07

5.  Cell loss and proliferation induced by N-2-fluorenylacetamide in the rat liver in relation to hepatoma induction.

Authors:  R E Albert; F J Burns; L Bilger; D Gardner; W Troll
Journal:  Cancer Res       Date:  1972-10       Impact factor: 12.701

6.  [Organotropic carcinogenic effects of 65 various N-nitroso- compounds on BD rats].

Authors:  H Druckrey; R Preussmann; S Ivankovic; D Schmähl
Journal:  Z Krebsforsch       Date:  1967

7.  Electron microscopic study of isolated Kupffer cells.

Authors:  D M Mills; D Zucker-Franklin
Journal:  Am J Pathol       Date:  1969-02       Impact factor: 4.307

8.  An improved fluorometric assay for DNA.

Authors:  R T Hinegardner
Journal:  Anal Biochem       Date:  1971-01       Impact factor: 3.365

9.  Effects of feeding the carcinogen dimethylnitrosamine on its metabolism and methylation of DNA in the mouse.

Authors:  L Den Engelse; P Emmelot
Journal:  Chem Biol Interact       Date:  1972-04       Impact factor: 5.192

10.  High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study.

Authors:  M N Berry; D S Friend
Journal:  J Cell Biol       Date:  1969-12       Impact factor: 10.539

View more
  2 in total

Review 1.  The role of DNA damage in chemical carcinogenesis of aromatic amines.

Authors:  H G Neumann
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

2.  Relationships between DNA adduct formation and carcinogenesis.

Authors:  J A Swenberg; F C Richardson; J A Boucheron; M C Dyroff
Journal:  Environ Health Perspect       Date:  1985-10       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.